LifeStance Health Group, Inc. (NASDAQ:LFST) Insider Danish J. Qureshi Sells 12,965 Shares of Stock

LifeStance Health Group, Inc. (NASDAQ:LFST) insider Danish J. Qureshi sold 12,965 shares of the company’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $5.93, for a total transaction of $76,882.45. Following the transaction, the insider now owns 4,911,050 shares in the company, valued at approximately $29,122,526.50. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

LifeStance Health Group Stock Performance

Shares of NASDAQ LFST opened at $5.71 on Friday. The business’s 50 day moving average price is $6.51 and its 200 day moving average price is $6.54. LifeStance Health Group, Inc. has a 52 week low of $4.74 and a 52 week high of $9.59. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.20.

LifeStance Health Group (NASDAQ:LFST) last announced its quarterly earnings results on Wednesday, February 28th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.03). The company had revenue of $280.60 million during the quarter, compared to analyst estimates of $263.14 million. LifeStance Health Group had a negative net margin of 17.64% and a negative return on equity of 12.66%. On average, equities analysts predict that LifeStance Health Group, Inc. will post -0.3 EPS for the current fiscal year.

Institutional Trading of LifeStance Health Group

Several large investors have recently added to or reduced their stakes in LFST. Price T Rowe Associates Inc. MD grew its holdings in shares of LifeStance Health Group by 10.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 13,623 shares of the company’s stock worth $102,000 after purchasing an additional 1,294 shares during the period. Osaic Holdings Inc. grew its stake in LifeStance Health Group by 6.1% during the 2nd quarter. Osaic Holdings Inc. now owns 23,141 shares of the company’s stock worth $211,000 after buying an additional 1,333 shares during the last quarter. Invesco Ltd. grew its stake in LifeStance Health Group by 13.2% during the 1st quarter. Invesco Ltd. now owns 16,817 shares of the company’s stock worth $170,000 after buying an additional 1,964 shares during the last quarter. Ameritas Investment Partners Inc. grew its stake in shares of LifeStance Health Group by 56.6% in the 1st quarter. Ameritas Investment Partners Inc. now owns 5,575 shares of the company’s stock valued at $56,000 after purchasing an additional 2,016 shares during the last quarter. Finally, Assetmark Inc. grew its stake in shares of LifeStance Health Group by 21.6% in the 4th quarter. Assetmark Inc. now owns 11,895 shares of the company’s stock valued at $93,000 after purchasing an additional 2,114 shares during the last quarter. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

LFST has been the topic of a number of recent analyst reports. Jefferies Financial Group raised their target price on shares of LifeStance Health Group from $8.00 to $9.00 and gave the stock a “buy” rating in a research note on Wednesday, March 6th. Barclays raised their target price on shares of LifeStance Health Group from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Thursday, February 29th. Finally, The Goldman Sachs Group raised their price target on LifeStance Health Group from $8.00 to $9.00 and gave the stock a “neutral” rating in a research report on Monday, March 4th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $8.60.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.